Events
Upcoming events
Silence Therapeutics Virtual Presentation at the Annual Needham Healthcare Conference - Live Webcast
New York, NY, 14 April 2020
Click here to register for the webcast.
Past events
London, UK, 25 March 2020
Click here to replay the webcast.
Silence Therapeutics presentation at the 2020 Cowen Health Care Conference
Boston, MA, 2 March 2020
Click here to replay the webcast.
New York, NY, 12 September 2019
Oligonucleotide & Peptide Therapeutics (OPT)
Boston, MA, 26-28 March 2019
David Horn Solomon, CEO, attended.
Cowen 39th Annual Health Care Conference
Boston, MA, 11 March 2019
Silence management hosted a webcast. Click here to replay the webcast.
JP Morgan Healthcare Conference
San Francisco, CA, 7-10 January 2019
Silence Therapeutics management team was in San Francisco
American Society of Hematology (ASH) Annual Meeting 2018
San Diego, CA, 29 November – 4 December 2018
Ute Schaeper, Discovery Research Project Leader, will be presenting
Haemochromatosis UK reception at The House of Commons
London, UK, 31 October 2018
David Horn Solomon, CEO, will attend
European Nephrology Conference
Warsaw, 15-16 October 2018
Steffen Schubert, Head of Pre-clinical Drug Discovery, attended
Cantor Fitzgerald 2018 Global Healthcare Conference
New York, NY, 3 October 2018
David Horn Solomon, CEO, presented
The webcast may be accessed by clicking here
Seattle, WA, 1-3 October 2018
Adrien Weingaertner, Group Leader - Drug Delivery, presented
London, UK, 11 September 2018
Investor call hosted by David Horn Solomon, CEO, and David Ellam, CFO
RNA Therapeutics: From Base Pairs to Bedside
Worcester, Umass, 28-29 June 2018
Marie Lindholm, Head of Technology Innovation, presented
European Hematology Association (EHA)
Stockholm, Sweden, 14-17 June 2018
Ute Schaeper, Discovery Research Project Leader, presented
2018 Bio International Convention
Boston, MA, 4-7 June 2018
Boston, MA, 7-10 May 2018
Torsten Hoffmann, CSO, presented
9th Clinical Trials Innovation Programme
Frankfurt, Germany, 26-27 April 2018
Torsten Hoffmann, CSO, presented
Oxford, UK, 10 April 2018
Adrien Weingaertner, Group Leader, Drug Delivery, presented
Rare Disease Symposium at OPT Congress
Boston, MA, 28 March 2018
Torsten Hoffmann, COO, presented and appeared as a panelist
Oligonucleotide & Peptide Therapeutics (OPT)
Boston, MA, 26-28 March 2018
Marie Lindholm, Head of Technology Innovation, presented
Cowen 38th Annual Health Care Conference
Boston, MA, 12-14 March 2018
Click here to register in advance for the live webcast. A replay of the webcast will be available for 14 business days through the same link
Presentation by Ali Mortazavi, CEO
London, UK, 6 March 2018
Kyoto, Japan, 27 February - 1 March 2018
Presentation by Torsten Hoffmann, COO
Afternoon session chaired by Torsten Hoffmann, COO
JP Morgan Healthcare Conference
San Francisco CA, 8-11 January 2018
14th International Conference on Thalassaemia & Haemoglobinopathies
Thessaloniki, Greece, 17-19 November 2017
London, UK, 14 November 2017
5th Canton Nucleic Acids Forum (CNAF)
Guangzhou, China, 9-10 November 2017
17th Annual Biotech in Europe Forum
Basel, Switzerland, 26-27 September 2017
Canaccord Genuity 37th Annual Growth
Boston MA, 9-10 August 2017
TIDES: Oligonucleotide and peptide therapeutics
San Diego CA, 30 April – 3 May 2017
OLIGO 2017 OXFORD
Antisense & Therapeutic Nucleic Acids
Oxford, UK, 10 April 2017
Oligonucleotide and Peptide Therapeutics
Boston MA, 26-29 March 2017
‘Therapeutic RNA delivery: into hepatocytes and beyond’
AsiaTIDES
Kyoto, Japan, 21-23 February 2017
EuroTides
Berlin, Germany, 14-16 November 2016